SE9202128D0 - Precipitation of one or more active compounds in situ - Google Patents

Precipitation of one or more active compounds in situ

Info

Publication number
SE9202128D0
SE9202128D0 SE9202128A SE9202128A SE9202128D0 SE 9202128 D0 SE9202128 D0 SE 9202128D0 SE 9202128 A SE9202128 A SE 9202128A SE 9202128 A SE9202128 A SE 9202128A SE 9202128 D0 SE9202128 D0 SE 9202128D0
Authority
SE
Sweden
Prior art keywords
situ
active compounds
precipitation
solution
administration
Prior art date
Application number
SE9202128A
Other languages
English (en)
Swedish (sv)
Inventor
F Broberg
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9202128A priority Critical patent/SE9202128D0/xx
Publication of SE9202128D0 publication Critical patent/SE9202128D0/xx
Priority to IS4037A priority patent/IS4037A/is
Priority to AT93915076T priority patent/ATE196990T1/de
Priority to AU45194/93A priority patent/AU676177B2/en
Priority to EP93915076A priority patent/EP0648112B1/en
Priority to CA002139505A priority patent/CA2139505C/en
Priority to JP50321794A priority patent/JP3809186B2/ja
Priority to ES93915076T priority patent/ES2152255T3/es
Priority to PCT/SE1993/000566 priority patent/WO1994001087A1/en
Priority to DK93915076T priority patent/DK0648112T3/da
Priority to PT93915076T priority patent/PT648112E/pt
Priority to FI950074A priority patent/FI950074A7/fi
Priority to DE69329576T priority patent/DE69329576T2/de
Priority to NO950049A priority patent/NO950049L/no
Priority to US08/563,880 priority patent/US5916583A/en
Priority to GR20010400036T priority patent/GR3035220T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9202128A 1992-07-09 1992-07-09 Precipitation of one or more active compounds in situ SE9202128D0 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9202128A SE9202128D0 (sv) 1992-07-09 1992-07-09 Precipitation of one or more active compounds in situ
IS4037A IS4037A (is) 1992-07-09 1993-06-21 Staðbundin útfelling eins eða fleiri virkra efna
DE69329576T DE69329576T2 (de) 1992-07-09 1993-06-24 Präzipitation einer oder mehrerer aktiver verbindungen in situ
JP50321794A JP3809186B2 (ja) 1992-07-09 1993-06-24 現場での１種又はそれ以上の活性化合物の析出
DK93915076T DK0648112T3 (da) 1992-07-09 1993-06-24 Udfældning af en eller flere active forbindelser in situ
EP93915076A EP0648112B1 (en) 1992-07-09 1993-06-24 Precipitation of one or more active compounds in situ
CA002139505A CA2139505C (en) 1992-07-09 1993-06-24 Precipitation of one or more active compounds in situ
AT93915076T ATE196990T1 (de) 1992-07-09 1993-06-24 Präzipitation einer oder mehrerer aktiver verbindungen in situ
ES93915076T ES2152255T3 (es) 1992-07-09 1993-06-24 Precipitacion in situ de uno o mas compuestos activos.
PCT/SE1993/000566 WO1994001087A1 (en) 1992-07-09 1993-06-24 Precipitation of one or more active compounds in situ
AU45194/93A AU676177B2 (en) 1992-07-09 1993-06-24 Precipitation of one or more active compounds in situ
PT93915076T PT648112E (pt) 1992-07-09 1993-06-24 Precipitacao in situ de um ou mais compostos activos
FI950074A FI950074A7 (fi) 1992-07-09 1993-06-24 Yhden tai useamman aktiivisen yhdisteen saostaminen in situ
NO950049A NO950049L (no) 1992-07-09 1995-01-05 Utfelling av en eller flere aktive forbindelser in situ
US08/563,880 US5916583A (en) 1992-07-09 1995-11-21 Precipitation of one or more active compounds in situ
GR20010400036T GR3035220T3 (en) 1992-07-09 2001-01-11 Precipitation of one or more active compounds in situ.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9202128A SE9202128D0 (sv) 1992-07-09 1992-07-09 Precipitation of one or more active compounds in situ

Publications (1)

Publication Number Publication Date
SE9202128D0 true SE9202128D0 (sv) 1992-07-09

Family

ID=20386754

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9202128A SE9202128D0 (sv) 1992-07-09 1992-07-09 Precipitation of one or more active compounds in situ

Country Status (16)

Country Link
US (1) US5916583A (is)
EP (1) EP0648112B1 (is)
JP (1) JP3809186B2 (is)
AT (1) ATE196990T1 (is)
AU (1) AU676177B2 (is)
CA (1) CA2139505C (is)
DE (1) DE69329576T2 (is)
DK (1) DK0648112T3 (is)
ES (1) ES2152255T3 (is)
FI (1) FI950074A7 (is)
GR (1) GR3035220T3 (is)
IS (1) IS4037A (is)
NO (1) NO950049L (is)
PT (1) PT648112E (is)
SE (1) SE9202128D0 (is)
WO (1) WO1994001087A1 (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE183092T1 (de) 1995-10-28 1999-08-15 Braun Melsungen Ag Lokalanästhetika und/oder zentralanalgetika enthaltende pharmazeutische zusammensetzungen
FR2748207B1 (fr) * 1996-05-06 1998-06-12 Cird Galderma Composition a base d'un compose modulant la reactivite des fibres nerveuses
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
EP1300141B1 (en) * 2000-06-06 2008-03-19 Lequio Pharma Co., Ltd. Medical composition kit for treating lesioned abnormal tissue
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US6607784B2 (en) * 2000-12-22 2003-08-19 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
MXPA04002446A (es) 2001-09-26 2004-07-23 Baxter Int Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente.
PL211116B1 (pl) * 2001-10-19 2012-04-30 Idexx Lab Komozycja do podawania ssakowi związku farmakologicznie czynnego i sposób wytwarzania preparatu do wstrzyknięć
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
FR2862872A1 (fr) * 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US20060052822A1 (en) * 2004-08-31 2006-03-09 Mirizzi Michael S Apparatus and material composition for permanent occlusion of a hollow anatomical structure
CN101146484B (zh) 2005-01-25 2015-04-08 泰科医疗集团有限合伙公司 用于永久性闭塞中空解剖结构的结构
JP2008543842A (ja) * 2005-06-14 2008-12-04 バクスター インターナショナル インコーポレイテッド 薬物−薬物相互作用を最小にするための薬学的処方物
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
WO2007002304A2 (en) 2005-06-22 2007-01-04 Vnus Medical Technologies, Inc. Methods and apparatus for introducing tumescent fluid to body tissue
AU2006315177A1 (en) * 2005-11-15 2007-05-24 Baxter Healthcare S.A. Compositions of lipoxygenase inhibitors
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
WO2014152466A1 (en) * 2013-03-14 2014-09-25 Jsn I, Llc Taste masking of anesthetics and analgesics
PL3049055T3 (pl) * 2013-09-27 2019-05-31 Anteis Sa Sposób otrzymywania hydrożelu do wstrzykiwań na bazie kwasu hialuronowego zawierającego lidokainę dodaną w postaci proszku oraz środek alkaliczny, sterylizowanego ciepłem
US20160367959A1 (en) * 2015-06-18 2016-12-22 Avon Products, Inc. Multiphase Compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268495A (en) * 1979-01-08 1981-05-19 Ethicon, Inc. Injectable embolization and occlusion solution
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4599354A (en) * 1985-03-11 1986-07-08 Morton Shulman Composition and method for producing prolonged pain relief
US4775659A (en) * 1985-08-19 1988-10-04 Eli Lilly And Company Injectable semi-solid formulations
US5051257A (en) * 1989-05-09 1991-09-24 Pietronigro Dennis D Antineoplastic solution and method for treating neoplasms
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
IT1242642B (it) * 1990-04-17 1994-05-16 Alfa Wassermann Spa Formulazioni iniettabili contenenti naproxen sale sodico.

Also Published As

Publication number Publication date
DK0648112T3 (da) 2000-11-27
CA2139505A1 (en) 1994-01-20
NO950049D0 (no) 1995-01-05
EP0648112B1 (en) 2000-10-18
FI950074A0 (fi) 1995-01-05
JP3809186B2 (ja) 2006-08-16
PT648112E (pt) 2001-01-31
US5916583A (en) 1999-06-29
AU676177B2 (en) 1997-03-06
JPH07509450A (ja) 1995-10-19
GR3035220T3 (en) 2001-04-30
EP0648112A1 (en) 1995-04-19
AU4519493A (en) 1994-01-31
CA2139505C (en) 2003-10-28
DE69329576D1 (de) 2000-11-23
ES2152255T3 (es) 2001-02-01
NO950049L (no) 1995-01-05
DE69329576T2 (de) 2001-03-08
FI950074L (fi) 1995-01-05
ATE196990T1 (de) 2000-11-15
FI950074A7 (fi) 1995-01-05
IS4037A (is) 1994-01-10
WO1994001087A1 (en) 1994-01-20

Similar Documents

Publication Publication Date Title
IS4037A (is) Staðbundin útfelling eins eða fleiri virkra efna
EA200200645A1 (ru) Ингибиторы каспазы и их применение
WO1993000095A3 (en) Bicyclic fibrinogen antagonists
BR0112068A (pt) Compostos orgânicos
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
FI944823A0 (fi) Galantamiinijohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
UA42819C2 (uk) Ін`єкційний та інфузійний розчин, що містить енрофлокcацин
ATE165357T1 (de) Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
ATE147625T1 (de) Hydantoin- oder imidazolidintrionderivate zur vorbeugung oder behandlung von niereninsuffizienz
KR930012036A (ko) 골 흡수 억제용 약제학적 조성물
DK0922054T3 (da) Antikoagulerende peptidylargininaldehydderivater
DE69319859D1 (de) Neue tetracyclische verbindungen
DE3880564D1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
EP0414903A4 (en) New thioproline derivative
KR940021524A (ko) 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법
ES2186923T3 (es) Derivados del 2-carboniltiazol y su utilizacion.
IL96506A0 (en) Transdermal system for administering pharmaceutical compounds under ph control
ES2052962T3 (es) Microbicidas.
CS247287A2 (en) Method of injection applicable water solutions antimetic agent stabilization
DK0641784T3 (da) Benzimidazolderivat, fremgangsmåde til fremstilling af dette, antiemetisk middel indeholdende dette som aktiv ingrediens sa
TH23095A (th) อนุพันธ์พิรโรโลคาร์บาโซล ซึ่งใช้เป็นสารเคมีรักษาโรค
TW360630B (en) A secoaporphine compounds on arrhythmia
KR920021561A (ko) 신규의 세팔로스포린 및 그의 제조 방법